Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Johnson and Johnson
Dow
Moodys
Express Scripts

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021145

See Plans and Pricing

« Back to Dashboard

NDA 021145 describes VANIQA, which is a drug marketed by Skinmedica and is included in one NDA. It is available from one supplier. Additional details are available on the VANIQA profile page.

The generic ingredient in VANIQA is eflornithine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eflornithine hydrochloride profile page.
Summary for 021145
Tradename:VANIQA
Applicant:Skinmedica
Ingredient:eflornithine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021145
Mechanism of ActionDecarboxylase Inhibitors
Medical Subject Heading (MeSH) Categories for 021145
Suppliers and Packaging for NDA: 021145
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145 NDA Allergan, Inc. 0023-4857 0023-4857-45 1 TUBE in 1 CARTON (0023-4857-45) > 45 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength13.9%
Approval Date:Jul 27, 2000TE:RLD:Yes

Expired US Patents for NDA 021145

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Skinmedica VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145-001 Jul 27, 2000   Start Trial   Start Trial
Skinmedica VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145-001 Jul 27, 2000   Start Trial   Start Trial
Skinmedica VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145-001 Jul 27, 2000   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
McKesson
Merck
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.